Fragility of Randomized Controlled Trials for Fluid Resuscitation in Acute Pancreatitis.
Dig Dis SciJul 8, 2026 (epub)
Anshuman Elhence, Abhishek Patel, Durga Prasanna Misra et al.
✦ AI-curated · Sources linked
In 30 seconds
This systematic review assessed the fragility of randomized controlled trials (RCTs) on fluid resuscitation in acute pancreatitis, analyzing 13 studies. The findings revealed that 75% of outcomes with significant results had a fragility index (FI) of ≤ 3, indicating a high level of fragility. The mean FI was 2.83, suggesting that many trials may not be robust.
Key findings
- 75% of outcomes with significant results had a fragility index (FI) of ≤ 3.
- Mean FI was 2.83, indicating a high level of fragility in the studies.
- 88.5% of outcomes were classified as fragile based on a fragility quotient (FQ) ≤ 0.10.
- 96.2% of results were fragile by any definition used in the study.
Why it matters
Understanding the fragility of RCTs in fluid resuscitation for acute pancreatitis is crucial for clinicians, as it highlights the need for more robust study designs to inform treatment decisions effectively.